Statin Current Events | Statin News | 5
|
| Page
5 of
6 |
117 Results |
|
|
|
Sort By:
Page Views | Date |
Older men with coronary heart disease missing out on statins
Older men with diagnosed coronary heart disease are missing out on statins, shows research in Heart. And inadequate doses are often being given to those who are prescribed the drugs. view more (2002-06-17)
Research provides clues to obesity's cause and hints of new approach for curbing appetite
Hot fudge sundaes and french fries aside, new research suggests obesity is due at least in part to an attraction between leptin, the hormone that signals the brain when to stop eating, and a protein more recently associated with heart disease. view more (2006-04-10)
First link found between obesity, inflammation and vascular disease
Researchers at The University of Texas M. D. Anderson Cancer Center and The University of Texas Health Science Center at Houston have found that human fat cells produce a protein that is linked to both inflammation and an increased risk of heart disease and stroke. view more (2005-09-19)
Cholesterol-lowering foods most effective when combined, U of T study
Cholesterol-lowering foods such as soy protein, almonds, plant sterol enriched margarines, oats and barley may reduce cholesterol levels more effectively when eaten in combination. view more (2006-03-08)
Statins pay off on a health-policy level, UCSF study finds
Current guidelines for when to prescribe popular cholesterol-lowering drugs called statins would produce cost-effective results and would save thousands of lives every year if they were followed more closely by physicians and patients, according to a new study led by researchers at the University of California, San Francisco. view more (2009-02-18)
Cholesterol-lowering drugs may help prevent stroke recurrence
People who take cholesterol-lowering drugs called statins after a stroke may be less likely to have another stroke later. view more (2009-05-26)
Calculating gene and protein connections in a Parkinson's disease model
Researchers have created an algorithm that meshes existing data to produce a clearer step-by-step flow chart of how cells respond to stimuli. Using this new method, Whitehead Institute and Massachusetts Institute of Technology scientists have analyzed alpha-synuclein toxicity to identify genes and pathways that can affect cell survival. Misfolded... view more... (2009-02-23)
Early use of statins after coronary syndromes does not reduce risk of heart attack, stroke or death
Beginning use of statins within 14 days of acute coronary syndromes (such as heart attack or unstable angina) does not decrease the risk of death, heart attack, or stroke, for up to 4 months, based on a meta-analysis of previously published studies. view more (2006-05-03)
Statins can protect against Alzheimer's disease, according to new study
High cholesterol levels are considered to be a risk factor not only for cardiovascular disease including stroke, but also for the development of Alzheimer's disease. view more (2009-06-22)
Traditional Risk Assessment Tools Do Not Accurately Predict Coronary Heart Disease
The Framingham and National Cholesterol Education Program tools, NCEP, do not accurately predict coronary heart disease, according to a study performed at the Yale University School of Medicine in New Haven, CT. view more (2009-01-07)
Simvastatin -- For hearts and minds?
Statins are not all equal when it comes to their potential to guard against dementia, according to a study published in the online open access journal BMC Medicine. view more (2007-07-19)
INEGY™ (Ezetimibe/Simvastatin) Receives First Approval in Europe
Merck & Co., Inc. and Schering-Plough Corporation today announced the regulatory approval of INEGY™ in Germany. INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or 'bad' cholesterol) through Dual Inhibition of both cholesterol production in the liver and absorption in the intestine. Germany is the first... view more... (2004-04-02)
Statins may exert influence on prostate cancer growth by reducing inflammation
Cholesterol-lowering drugs called statins may reduce inflammation in prostate tumors, possibly hindering cancer growth, according to a study led by investigators in the Duke Prostate Center. view more (2009-04-27)
Aspirin treatment failure warning
Treatment failures occur with any drug and aspirin is no exception. Evidence is growing that some people will not respond to the anti-coagulant action of aspirin and the drug will not protect against cardiovascular events despite its regular intake. view more (2005-08-10)
Statins may treat blood vessel disorder that can lead to fatal strokes
In a finding that could save thousands of lives a year, University of Utah School of Medicine researchers have shown that a blood vessel disorder leading to unpredictable, sometimes fatal, hemorrhagic strokes, seizures, paralysis or other problems is treatable with the same statin drugs that millions of people take to control high cholesterol. view more (2009-01-27)
Article analyzes relationship of apolipoprotein E genotypes with lipid levels and coronary risk
An analysis of previously published studies suggests that there are approximately linear relationships of apolipoprotein E genotypes with lipid levels and with coronary risk view more (2007-09-19)
Cholesterol screening a cost-effective procedure to extend life in Hodgkin's disease survivors
Hodgkin's lymphoma survivors who have lipid screening every five years to detect high cholesterol will live a half year longer than patients who don't have the screening and the intervention is cost-effective. view more (2006-11-09)
ESC Congress 2004: Trial supports early, aggressive statin use after heart attack
Patients suffering from acute coronary syndromes should be treated with cholesterol-lowering drugs known as statins early and aggressively, according to the results of an international clinical trial led by a team of investigators at the Duke Clinical Research Institute, the University of Texas Southwestern Medical Center and the Brigham and... view more... (2004-08-30)
The mechanism of the life-threatening drug-interaction of Bayer's cholesterol-lowering agent Lipobay/Baycol clarified
Researchers from Finland have found that the cholesterol-lowering agent gemfibrozil (marketed as Lopid and generics) greatly increases the concentrations of cerivastatin (Lipobay or Baycol) in blood. This finding explains the observed muscle toxicity of the gemfibrozil-cerivastatin combination. This potentially fatal adverse effect of cerivastatin... view more... (2002-12-16)
Rheumatoid arthritis is a risk factor for cardiovascular disease
The risk of cardiovascular disease (CVD) for people with rheumatoid arthritis (RA) has been found to be comparable to the risk of CVD in people with type 2 diabetes. view more (2008-06-16)
|
|
| Page
5 of
6 |
117 Results |
|
|
|
Sort By:
Page Views | Date |
|
